No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹78Prev. Close
₹76.1Turnover(Lac.)
₹52.71Day's High
₹79.45Day's Low
₹74.7552 Week's High
₹10052 Week's Low
₹50.31Book Value
₹48.43Face Value
₹10Mkt Cap (₹ Cr.)
220.74P/E
56.36EPS
1.4Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 33.49 | 32.99 | 30.02 | 27.7 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 105 | 99.79 | 87.39 | 85.94 |
Net Worth | 138.49 | 132.78 | 117.41 | 113.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 348.41 | 300.08 | 349.34 | 395.96 |
yoy growth (%) | 16.1 | -14.1 | -11.77 | 60.94 |
Raw materials | -337.79 | -290.18 | -337.36 | -382.98 |
As % of sales | 96.95 | 96.69 | 96.56 | 96.72 |
Employee costs | -0.39 | -0.39 | -0.38 | -0.33 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 8.3 | 7.24 | 8.19 | 7.97 |
Depreciation | -0.92 | -0.89 | -0.71 | -0.64 |
Tax paid | -1.78 | -1.44 | -2.01 | -2.5 |
Working capital | 6.66 | 26.65 | 23.78 | 5.56 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.1 | -14.1 | -11.77 | 60.94 |
Op profit growth | 43.51 | -57.69 | -20.51 | 848.64 |
EBIT growth | 18.89 | -10.71 | -17.84 | 248.55 |
Net profit growth | 12.44 | -6.21 | 12.85 | 324.54 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,807.7 | 144.46 | 4,33,619.81 | 608.7 | 0.89 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,638 | 66.14 | 1,76,086.64 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,571.2 | 69.99 | 1,54,837.1 | 467 | 0.83 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,389.4 | 32.59 | 1,12,193.56 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,104.7 | 30.09 | 1,11,123.45 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
Mihir R Ghatalia
E D & Wholetime Director
Nimit R Ghatalia
Non-Exec & Non-Independent Dir
BINA RAJESH GHATALIA
Independent Non Exe. Director
Chetan K Mehta
Independent Non Exe. Director
Lalit R Tulsiani
Independent Non Exe. Director
Anil Mandal
Company Sec. & Compli. Officer
KAILASH CHAND JETHLIA
E-34 MIDC Tarapur,
Boisar,
Maharashtra - 401506
Tel: 91-22-23455543
Website: http://www.aareydrugs.com
Email: investorgrievance@aareydrugs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited. The company was or...
Read More
Reports by Aarey Drugs & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.